Ocular Ischemic Syndrome as A Cause of Chronic Visual Loss: Case Report and Review Literature
Keywords:
ocular ischemic syndrome, visual lossAbstract
We reported a 68-year-old man, known case of hypertension, diabetes mellitus type 2, hyperlipidemia, ex-smoker and laryngeal cancer status post total laryngectomy and radiation therapy 14 years ago, presented with progressive bilateral visual loss for 1 year. Eyes examinations and vascular investigations are compatible with the findings of ocular ischemic syndrome that caused by carotid occlusive disease of bilateral carotid system.
References
1. Brown GC, Magargal LE. The ocular ischemic syndrome. Clinical, fluorescein angiographic and carotid angiographic features. Int Ophthalmol. 1988;11:239-51.
2. Mendrinos E, Machinis TG, Pournaras CJ. Ocular ischemic syndrome. Surv Ophthalmol. 2010;55(1):2-34.
3. Terelak-Borys B, Skonieczna K, Grabska-Liberek I. Ocular ischemic syndrome - a systematic review. Med Sci Monit. 2012;18(8):138-144.
4. Kim YH, Sung MS, Park SW. Clinical Features of Ocular Ischemic Syndrome and Risk Factors for Neovascular Glaucoma. Korean J Ophthalmol. 2017; 31(4):343-350.
5. Luo J, Yan Z, Jia Y, Luo R. Clinical Analysis of 42 Cases of Ocular Ischemic Syndrome. J Ophthalmol. 2018;2018:2606147.
6. Wang H, Wang Y, Li H. Research Article. Multimodality Imaging Assessment of Ocular Ischemic Syndrome. J of Ophthalmol 2017(1):1-9.
7. Aasen J, Kerty E, Russell D, Bakke SJ, Nyberg-Hansen R. Amaurosis fugax: clinical, Doppler and angiographic findings. Acta Neurol Scand 1988;77:450-5.
8. Sivalingam A, Brown GC, Magargal LE. The ocular ischemic syndrome. III. Visual prognosis and the effect of treatment. Int Ophthalmol 1991;15:15-20.
9. GrantEG,BensonCB,MonetaGL,Alexandrov AV, Baker JD, Bluth EI, et al. Carotid Artery Stenosis: Gray-Scale and Doppler US Diagnosis—Society of Radiologists in Ultrasound Consensus Conference. Radiology. 2003;229(2):340-6.
10. Byrnes KR, Ross CB. Review Article. The Current Role of Carotid Duplex Ultrasonography in the Management of Carotid Atherosclerosis: Foundations and Advances. Int J Vasc Med. 2012; 2012: 187872.
11. Ho AC, Lieb WE, Flaharty PM, Sergott RC, Brown GC, Bosley TM, et al. Color Doppler imaging of the ocular ischemic syndrome. Ophthalmology 1992;99(9):1453-62.
12. Sun YH, Yang YH, Huang YC, Chang CH, Hwang YH. Case report. Reverse flow in ophthalmic artery helps protect the cerebrum from ischemic stroke in total carotid artery occlusion. Taiwan J of Ophthalmol. 2013(3):78-81.
13. Chen YY, Lin LY, Chang PY, Chen FT, Mai ELC, Wang JK. Laser and Anti-Vascular Endothelial Growth Factor Agent Treatments for Retinal Arterial Macroaneurysm. Asia Pac J Ophthalmol (Phila). 2017;6(5):444-449.
14. Cho HJ, Rhee TK, Kim HS, Han Ji, Lee DW, Cho SW, et al. Intravitreal bevacizumab for symptomatic retinal arterial macroaneurysm. Am J Ophthalmol. 2013;155(5):898-904.
15. Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/ SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease. Circulation. 2011;124:e54-e130.
16. Kawaguchi S, Sakaki T, Kamada K, et al. Effects of superficial temporal to middle cerebral artery bypass for ischaemic retinopathy due to internal carotid artery occlusion/stenosis. Acta Neurochir (Wien) 1994;129:166–70.
17. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/ American Stroke Association. Stroke. 2018;49(3):e46-e110.
2. Mendrinos E, Machinis TG, Pournaras CJ. Ocular ischemic syndrome. Surv Ophthalmol. 2010;55(1):2-34.
3. Terelak-Borys B, Skonieczna K, Grabska-Liberek I. Ocular ischemic syndrome - a systematic review. Med Sci Monit. 2012;18(8):138-144.
4. Kim YH, Sung MS, Park SW. Clinical Features of Ocular Ischemic Syndrome and Risk Factors for Neovascular Glaucoma. Korean J Ophthalmol. 2017; 31(4):343-350.
5. Luo J, Yan Z, Jia Y, Luo R. Clinical Analysis of 42 Cases of Ocular Ischemic Syndrome. J Ophthalmol. 2018;2018:2606147.
6. Wang H, Wang Y, Li H. Research Article. Multimodality Imaging Assessment of Ocular Ischemic Syndrome. J of Ophthalmol 2017(1):1-9.
7. Aasen J, Kerty E, Russell D, Bakke SJ, Nyberg-Hansen R. Amaurosis fugax: clinical, Doppler and angiographic findings. Acta Neurol Scand 1988;77:450-5.
8. Sivalingam A, Brown GC, Magargal LE. The ocular ischemic syndrome. III. Visual prognosis and the effect of treatment. Int Ophthalmol 1991;15:15-20.
9. GrantEG,BensonCB,MonetaGL,Alexandrov AV, Baker JD, Bluth EI, et al. Carotid Artery Stenosis: Gray-Scale and Doppler US Diagnosis—Society of Radiologists in Ultrasound Consensus Conference. Radiology. 2003;229(2):340-6.
10. Byrnes KR, Ross CB. Review Article. The Current Role of Carotid Duplex Ultrasonography in the Management of Carotid Atherosclerosis: Foundations and Advances. Int J Vasc Med. 2012; 2012: 187872.
11. Ho AC, Lieb WE, Flaharty PM, Sergott RC, Brown GC, Bosley TM, et al. Color Doppler imaging of the ocular ischemic syndrome. Ophthalmology 1992;99(9):1453-62.
12. Sun YH, Yang YH, Huang YC, Chang CH, Hwang YH. Case report. Reverse flow in ophthalmic artery helps protect the cerebrum from ischemic stroke in total carotid artery occlusion. Taiwan J of Ophthalmol. 2013(3):78-81.
13. Chen YY, Lin LY, Chang PY, Chen FT, Mai ELC, Wang JK. Laser and Anti-Vascular Endothelial Growth Factor Agent Treatments for Retinal Arterial Macroaneurysm. Asia Pac J Ophthalmol (Phila). 2017;6(5):444-449.
14. Cho HJ, Rhee TK, Kim HS, Han Ji, Lee DW, Cho SW, et al. Intravitreal bevacizumab for symptomatic retinal arterial macroaneurysm. Am J Ophthalmol. 2013;155(5):898-904.
15. Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/ SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease. Circulation. 2011;124:e54-e130.
16. Kawaguchi S, Sakaki T, Kamada K, et al. Effects of superficial temporal to middle cerebral artery bypass for ischaemic retinopathy due to internal carotid artery occlusion/stenosis. Acta Neurochir (Wien) 1994;129:166–70.
17. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/ American Stroke Association. Stroke. 2018;49(3):e46-e110.
Downloads
Published
2019-08-20
How to Cite
1.
คงสาคร น, แสงวณิช ศ. Ocular Ischemic Syndrome as A Cause of Chronic Visual Loss: Case Report and Review Literature. J Thai Stroke Soc [Internet]. 2019 Aug. 20 [cited 2024 Dec. 26];18(2):84-93. Available from: https://he01.tci-thaijo.org/index.php/jtss/article/view/185653
Issue
Section
Case Report
License
ข้อความภายในบทความที่ตีพิมพ์ในวารสารสมาคมโรคหลอดเลือดสมองไทยเล่มนี้ ตลอดจนความรับผิดชอบด้านเนื้อหาและการตรวจร่างบทความเป็นของผู้นิพนธ์ ไม่เกี่ยวข้องกับกองบรรณาธิการแต่อย่างใด การนำเนื้อหา ข้อความหรือข้อคิดเห็นของบทความไปเผยแพร่ ต้องได้รับอนุญาตจากกองบรรณาธิการอย่างเป็นลายลักษณ์อักษร ผลงานที่ได้รับการตีพิมพ์ในวารสารเล่มนี้ถือเป็นลิขสิทธิ์ของวารสาร
